EAGLE Trial CADDIE Artificial Intelligence Endoscopy (EAGLE)
Colorectal Cancer, Polyp of Colon, Adenoma Colon
About this trial
This is an interventional diagnostic trial for Colorectal Cancer focused on measuring Screening, Surveillance, Artificial Intelligence, Colonoscopy
Eligibility Criteria
Inclusion Criteria: Screening or surveillance colonoscopy Age 40 years or older Informed consent Exclusion Criteria: Emergency colonoscopies Inflammatory bowel disease (IBD) Colorectal Cancer (CRC) Previous Colorectal Cancer (CRC) Previous colonic resection Returning for a planned elective therapeutic colonoscopy. Polyposis syndromes (familial adenomatous polyposis) Contraindication for biopsy or polypectomy.
Sites / Locations
- Israeli-Georgian Medical Research Clinic HealthycoreRecruiting
- Sana Klinikum LichtenbergRecruiting
- Humanitas Mater DominiRecruiting
- Humanitas CataniaRecruiting
- Humanitas Research HospitalRecruiting
- H-T. Centrum MedyczneRecruiting
- The Maria Sklodowska-Curie National Research Institute of OncologyRecruiting
- Przychodnia Polskiej Fundacji GastroenterologiiRecruiting
- University Hospital "Clinico Lozano Blesa" of ZaragozaRecruiting
- University College Hospital London
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
CADDIE colonoscopy (CADDIE Arm)
Standard high-definition white light colonoscopy (Control Arm)
CADDIE is a computer-assisted detection (CADe) device used in conjunction with endoscopy for the detection of abnormal lesions in the gastrointestinal tract.
Patients will receive a standard colonoscopy